Anti-HIV Gel

  • Author: ChemistryViews
  • Published: 21 July 2010
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Nature
thumbnail image: Anti-HIV Gel

An antiretroviral microbicide gel can cut HIV infection in women by more than 50 % if used consistently.

Quarraisha Abdool Karim, Centre for the AIDS Program of Research in South Africa (CAPRISA), Durban, and her colleagues tested a 1 % vaginal gel formulation of the antiretroviral drug tenofovir, manufactured by Gilead Sciences, Foster City, California. The study involved 889 women in South Africa aged between 18 and 40 years who were HIV-negative, sexually active and at high risk of HIV infection.

Unexpectedly, the gel was also shown to reduce Herpes simplex virus 2 (HSV-2) infections by 51 %. The formulation is the first to successfully prevent HSV-2, which is important, because the risk of becoming infected with HIV doubles for women with HSV-2.

More tests have to be performed, a tenofovir gel product will not be available for at least a year or two.

Article Views: 2860

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH